Business news – Page 62
-
NewsPfizer launches new biosimilar drug in US
Autoimmune disease treatment becomes only the second biosimilar to be approved by the FDA
-
BusinessThird fatality confirmed in BASF incident
Crackers and related plants will restart over coming days
-
PodcastGabapentin
Louise Crane documents the rise and fall of Gabapentin – from ‘wonder drug’ to illicit substance in just 50 years
-
NewsWax pills for safe and simple olefin metathesis hit the market
Capsules preserve air-sensitive chemicals and forego need for glove boxes
-
BusinessExplosion at BASF kills at least two
Six workers injured and a further two missing in Ludwigshafen, Germany
-
BusinessTroubled Theranos abandons clinical testing
Seeking to salvage some value, once-admired blood analysis firm lays off 40% of staff
-
BusinessNovartis consolidates research sites
Company will close research sites in China and Switzerland, and relocate another from Singapore to US
-
BusinessChemical activity on demand
Aqdot controls the release of encapsulated cargoes using supramolecular chemistry
-
BusinessIndia’s Intas bags UK and Irish generics
Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
-
BusinessPfizer to sell Hospira Infusion Systems to ICU Medical
$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics
-
BusinessLilly to buy Boehringer’s pet vaccines
Deal strengthens Lilly’s animal medicine division following recent acquisition
-
FeatureIonic liquids revisted
Ionic liquids have flowed far and wide since they first bubbled to the surface in the late 1990s. Michael Freemantle reports
-
BusinessWest Virginia chemical leak was preventable
2014 spill that contaminated water supplies was caused by lack of proper tank inspections and repairs
-
BusinessNovo Nordisk to axe 1000 jobs
Diabetes specialist is cutting costs in the face of increased competition
-
BusinessAccidents prompt Chinese industry safety push
Government aims to close or relocate chemical plants to reduce incidents in populated areas
-
OpinionBooster shot
Zika and Ebola have highlighted the pharmaceutical industry’s ability to respond to critical needs
-
BusinessLanxess to buy Chemtura for additives
€2.4 billion deal brings lubricant additives and flame retardants expertise and expands North American operations
-
BusinessPfizer scraps plans to split
Previously separated ‘innovative’ and ‘value’ business segments will remain autonomous under Pfizer umbrella
-
NewsPharma giants commit to tackling antimicrobial resistance
Plan to tackle superbugs includes changes to manufacturing and sales incentives
-
BusinessIneos lands first US shale gas in UK
Massive tankers create a ‘virtual pipeline’ bringing feedstock to replace dwindling domestic supplies